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Abstract
Venous thromboembolism is a common complication following surgical procedures. It
is imperative for us to identify which risks factors are present in our patients, not only
because  body  sculpting  procedures  are  elective,  but  also  to  help  us  perform  an
individualized assignment of venous thromboembolism risk. Once we have identified
the risk, we can select a method of venous thromboembolism prophylaxis based on the
guidelines by the American College of Chest Physicians and the other individualized
risk scales presented in this chapter. Our main goal is to keep as low as possible the
incidence of venous thromboembolism and its complications.
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1. Introduction
Body sculpting procedures can be associated to postoperative venous thromboembolism in
patients with certain characteristics. This entity can lead to fatal consequences, like pulmonary
embolism and death, that is why it is important for us to clearly assess the risk for each individual
in the preoperative setting, in order to establish certain procedures and prophylaxis, which may
help us lower or diminish these risks to the minimum. Given these are elective procedures, it
should be our main concern that our patients are well prepared before the surgery with a complete
preoperatory analysis of the risks both the patient and the surgery per se represent.
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2. Background
Venous thromboembolism represents a wide spectrum of disease, ranging from deep venous
thrombosis to pulmonary embolism, a very relevant complication following body sculpting
procedures, especially those who combine two or three procedures in one surgery. Some
studies have reported that each year 350,000–600,000 Americans suffer from deep venous
thrombosis and pulmonary embolism and that at least 100,000 deaths are directly or indirectly
related to venous thromboembolism [1]. These numbers represent the incidence in general
population, not specifically following body sculpting procedures, nevertheless some studies
in the last few years have discussed this matter.
Some data collected from a worldwide survey among certificated plastic surgeons revealed
pulmonary embolism as the main cause of death following a liposuction, which represented
the 23% of all deaths [2]. Another study that included all the procedures performed inside an
operating room reported that 63.6% of the postoperative deaths were secondary to throm‐
boembolism [3]. Considering large‐volume liposuction procedures, Albin and de Campo
reported an incidence of venous thromboembolism of 1.7% in patients where the aspirated
volume was larger than 5 L [4]. Grazer and Goldwyn cited a 1.9% incidence of venous
thromboembolism in a series of abdominoplasty patients [5]. Finally, in combined procedures
and with longer surgical times as belt lipectomies, there is a higher incidence of thromboemb‐
olism, as reported by Aly and colleagues with a 9.4% incidence in this group of patients [6].
Given these high rates of mortality following venous thromboembolism complicated with
pulmonary embolism after body sculpting procedures, it should be logic for us to think that
the surgeons performing these procedures would establish a prophylaxis protocol in all their
patients in order to lower the risk of the development of venous thromboembolism. Never‐
theless, some worldwide studies have reported that only 43.7% of the surgeons performing
liposuction procedures and 60.8% of the surgeons performing a combined body sculpting
procedure use thromboembolism prophylaxis [7]. This can be secondary to the belief that
venous thromboembolism has a low incidence, or because of the fear to have bleeding
complications and postoperative hematomas, with dehiscence of wound and infection.
3. Risk factors
In order to develop a venous thromboembolism, two variables must be present interacting
between them: first, the individual patient’s risk factors which cannot be modified and are
usually permanent and second, the circumstances surrounding the time and place where the
thromboembolism occurs, being transient in nature, with the possibility to be modified most
of the times.
Risk factors inherent to the patient include age, active malignancy, history of venous throm‐
boembolism, other chronic diseases such as heart or respiratory failure, spinal cord injury,
multiple trauma, myocardial infarction, congenital or acquired coagulation disorders (antith‐
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rombin deficiency, Protein C and Protein S deficiency, elevated coagulation factors), hormone
replacement therapy, and oral contraception. Critically ill patients receiving intensive care are
also considered to be a population at risk for developing venous thromboembolism.
According to the British Thoracic Society, patient risk factors are traditionally classified into
major and minor categories (Table 1) [8]. Remember, these predisposing factors cannot be
modified, so the seldom presence of them justifies the use of prophylaxis. The important thing
here is not only to be able to identify those factors, but also to assess the overall risk of venous
thromboembolism in each patient and to establish the appropriate prophylaxis regimen in each
case [9].
Major risk factors (RR = 5–20) Minor risk factors (RR = 2–4)
Postoperative state: major abdominal/pelvic
surgery, hip/knee joint replacement,
postoperative intensive care
Cardiovascular: congenital heart disease, heart failure, hypertension,
superficial venous thrombosis, central venous catheter
Obstetrics: late pregnancy, caesarian section,
puerperium
Humoral: estrogen use: oral contraception, hormone replacement
therapy
Lower limb affections: fractures, extensive
varicosities
Miscellaneous: chronic obstructive lung disease, neurological
impairment, latent malignancy, thrombotic defects, long‐distance
travel in the sitting position, obesityMalignancies: abdominal/pelvic, advanced/
metastatic stage
Limited mobility: hospitalization geriatric care Other: inflammatory bowel disease, nephrotic syndrome, chronic
dialysis, myeloproliferative disease, paroxysmal nocturnal
hemoglobinuria
Miscellaneous: history of previous venous
thromboembolism
Table 1. Risk factor of venous thromboembolism, according to the British Thoracic Society [8].
Besides these risk factors inherent to the patient, the surgical procedure per se represents also
a risk factor to the patient. General anesthesia, supine position as well as immobilization
produce blood stasis. Decreased venous return also diminishes the clearance of activated
clotting factors, which in turn augments the hypercoagulable state. Finally, intimal injury is
secondary to venous traction and to the vasodilatory effect of anesthesia, which favors platelets
deposits in the sites of vascular injury, initiating the coagulation cascade.
4. Natural history of venous thromboembolism
As described earlier in this chapter, venous thromboembolism includes various stages of
complex developments, which can be fatal as they lead the patient to a pulmonary embolism.
Regardless of the patient’s risk factors, the surgery alone is one of the most important risk
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factors we will face. During surgery, the patient will be prone to stasis, hypercoagulability and
endothelial injury, which in turn can explain how 50% of deep vein thrombosis associated with
surgery start intraoperatively. The first affected veins will be the most distal ones, located at
the calf region. Of these affected cases, approximately 50% may resolve spontaneously within
72 h with the use of adequate venous thromboprophylaxis, which will help in the lysis of
thrombi and prevent the formation of new ones. When the deep vein thrombosis is isolated to
the calf, it will rarely cause leg symptoms or clinically important pulmonary embolisms [10].
Of the untreated symptomatic calf deep vein thromboses, approximately 25% will extend to
more proximal veins as late as 1 week after the surgery, and subsequently break free to cause
pulmonary embolism in the late stages. Each of these stages may or may not be associated with
symptoms. The development of symptoms depends on the extent of thrombosis, the adequacy
of collateral vessels, and the severity of associated vascular occlusion and inflammation.
In those cases where the thrombi moves in a more proximal direction toward the inguinal
region and it is symptomatic but without chest symptoms, approximately 50% of the patients
will have a pulmonary embolism on lung scan [11]. From day 3 to day 7 of the postoperative
period the patient will be at the highest risk of the development of fatal pulmonary embolism,
being fatal around 10% of symptomatic pulmonary embolisms within one hour of first
symptoms. Furthermore, the patient will be at the highest risk of developing symptomatic
venous thromboembolism within 2 weeks of surgery, but that risk will remain elevated for 2–
3 months [12].
The severity of acute pulmonary embolism is determined primarily by its hemodynamic
impact, presenting as sudden pulmonary hypertension. In healthy patients, it is known that a
pulmonary bed obstruction of 30–50% is needed in order to develop pulmonary hypertension
[13]. In the other hand, patients with a previous history of lung or heart disease will develop
pulmonary hypertension with even a minor obstruction in the pulmonary circulation. The
acutely developing pulmonary hypertension in pulmonary embolism leads to an increase in
right ventricular after load, morphologically presenting as right ventricular dilation and may
eventually cause right heart failure, which results in decreasing of left ventricular filling, and
deteriorated diastolic left ventricular function due to right ventricular dilation. After a
diagnosed pulmonary embolism, 50% of patients have right ventricular dysfunction on
echocardiography. These events can lead to a fall in blood pressure and present as syncope,
hypotension or carcinogenic shock, resulting in sudden death [14]. After a symptomatic deep
vein thrombosis, there is an approximately 10% cumulative incidence of severe postthrombotic
syndrome after 5 years.
5. Assessment of postoperative venous thromboembolism risk
In each patient to undergo a surgical body contouring procedure should be implemented a
strategic scheme of risk assessment, planning and establish measures to reduce morbidity and
mortality [15]. We must identify the preventive management of hypercoagulable states. Risk
stratification will allow us to make good decisions, especially in patients at high risk.
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Over the past two decades, thromboprophylaxis has taken greater importance, given the
increase in the number of surgical procedures performed in the body contour area. Because of
this, there have been designed, applied, and evaluated various risk models for venous
thromboembolism [16–19]. The most widely known and validated model is the one developed
by Caprini et al.
This model was initially published in 1991 [20], which with the passage of time has been
modified and refined. In the published version of 2005, plastic and reconstructive surgery
patients were included, predicting the risk of venous thromboembolism within 30 or 60 days
(Figure 1) [21]. As a result of these validation studies, strata have been identified to report level
of risk and response to prophylaxis based on risk level [22–23].
Figure 1. The 2005 Caprini risk assessment model. COPD, chronic obstructive pulmonary disease; DVT, deep venous
thrombosis; PE, pulmonary embolism. Caprini, Thrombosis risk assessment as a guide to quality patient care. 2005.
The most recent version of the Caprini Risk Assessment Model was published in 2010
(Figure 2) [24]. When compared with the 2005 Risk Assessment Model, the 2010 Risk Assess‐
ment Model has four distinct, data‐driven changes, including addition of new risk factors or
reweighting of old risk factors. Some studies have shown that Caprini 2010 model gives an
altered estimate of the risk of thromboembolism with consequent inappropriate application
of preventive measures, so what right now the evidence does not support is its use in patient
stratification until it is validated more widely [25].
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Figure 2. The 2010 Caprini risk assessment model. Risk assessment as a guide to thrombosis prophylaxis. Curr Opin
Pulm Med. 2010.
The 2012 American College of Chest Physicians guidelines note that at any level of 2005 Caprini
score, plastic and reconstructive surgery patients are at decreased risk of venous thromboemb‐
olism compared with patients undergoing abdominal and pelvic surgery [26]. Prior validation
studies of the 2005 Caprini score in plastic and reconstructive surgery patients [27] and the
head and neck surgery population [28] showed that 70–80% of patients in the overall popula‐
tion are classified as lower risk (2005 Caprini scores of 3–4 or 5–6). Thus, only a small proportion
of patients fall into the highest risk strata.
We recommend that all plastic and reconstructive surgery patients should be risk‐stratified for
perioperative venous thromboembolism risk using a 2005 Caprini score and that surgeons
consider chemoprophylaxis on a case‐by‐case basis in patients with Caprini score >8.
6. Thrombosis and venous thromboembolism prophylaxis
Venous stasis is a recognized venous thromboembolism risk factor. Stasis, along with hyper‐
coagulability and intimal damage, constitutes the central tenets of Virchow’s triad for throm‐
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bosis. Stasis also promotes venous dilation, resulting in intimal microtears. This exposes
subendothelial collagen and initiates the clotting cascade. Venous dilation is known to predict
deep venous thrombosis in other surgical subspecialties [29].
In recent years there has been consensus in plastic surgery looking forward to find the best
available evidence on prevention, taking into account the best scientific articles of all specialties
related to venous thrombosis. The most important aspects for a surgeon about this issue are
enlisted.
7. Type of anesthesia
General anesthesia, paralysis, or both eliminate calf muscle pump action in the lower extrem‐
ities. The calf muscle pump propels venous blood cranially and, in concert with the venous
valve system, mitigates venous stasis and venous dilation. A recent study of 200 patients
having elective plastic surgery under spontaneous breathing, avoid gas, face up, extremities
mobile (SAFE) anesthesia with postoperative duplex ultrasound screening showed an
asymptomatic deep venous thrombosis rate of 0.5%. This rate is similar to symptomatic venous
thromboembolism rates among low‐risk (2005 Caprini score of 3 or 4) plastic surgery in
patients undergoing surgery under general anesthesia [21, 30]. The recommendation on this
issue is limited by the fact that some operations require general anesthesia, and thus this
recommendation is not applicable to all patients.
Pannucci et al. [25] recommend using non‐general anesthesia when appropriate. When
possible, consideration should be given to using monitored anesthesia care, local anesthesia
with sedation, or neuraxial anesthesia instead of general anesthesia with a grade 1C level of
evidence (Table 2) [31].
Grade Description Benefit vs risk and
burdens
Quality of supporting
evidence
Implications
1A Strong
recommendation,
high‐quality
evidence
Benefits clearly
outweigh risks and
burdens,
or vice versa
RCTs without important
limitations or
overwhelming evidence
from observational
studies
Strong recommendation
and can apply to most
patients in most
circumstances
without reservation
1B Strong
recommendation,
moderate‐quality
evidence
Benefits clearly
outweigh risks and
burdens,
or vice versa
RCTs with important
limitations or
exceptionally strong
evidence from
observational studies
Strong recommendation
and can apply to most
patients in most
circumstances
without reservation
1C Strong
recommendation
low‐ or very
low‐quality
Benefits clearly
outweigh risks and
burdens,
or vice versa
Observational studies or
case series
Strong recommendation
but may change when
higher quality evidence
becomes available
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Grade Description Benefit vs risk and
burdens
Quality of supporting
evidence
Implications
evidence
2A Weak
recommendation,
high‐quality evidence
Benefits closely
balanced with risks
and burden
RCTs without important
limitations or
overwhelming evidence
from observational
studies
Weak recommendation,
best action may differ
depending on circumstances
or patient’s
or societal values
2B Strong
recommendation
moderate‐quality
evidence
Benefits closely
balanced with risks
and burden
RCTs with important
limitations or
exceptionally strong
evidence from
observational studies
Weak recommendation,
best action may differ
depending on circumstances
or patient’s
or societal values
2C Weak
recommendation
low‐ or very
low‐quality
evidence
Uncertainty in the
estimated of benefits
risks, and burden;
benefits, risk, and
burden may be closely
balanced
Observational studies or
case series
Very weak
recommendation; other
alternatives may
be equally reasonable
Reproduced from Guyatt et al. [31].
Table 2. RCTs (randomized controlled trials).
8. Use of pneumatic compression and/or elastic stockings
Elastic stockings (also known as graduated compression stockings) may preferentially shunt
venous blood from the superficial to the deep venous system through perforating veins.
Shunting augments the volume and velocity within the deep venous system, theoretically
decreasing stasis and the likelihood of thrombosis [32, 33]. Elastic stockings are significantly
more effective than no stockings for both deep venous thrombosis and pulmonary embolus
prevention in general and orthopedic surgery patients [33].
Intermittent pneumatic compression devices (also known as sequential compression devices)
work by means of multiple mechanisms. The sequential compression serially “pumps” blood
from caudal to cranial, using the venous valve system to facilitate egress of venous blood and
minimizing venous stasis and venous dilation. Intermittent pneumatic compression also
stimulates the body’s endogenous fibrinolytic mechanism. Blood samples taken distant from
the intermittent pneumatic compression site show stimulation of bloodborne fibrinolytic
activity when intermittent pneumatic compression is applied. Thus, intermittent pneumatic
compression applied to a single leg can provide deep venous thrombosis risk reduction by
means of both a direct and an indirect mechanism [34]. A meta‐analysis by Ho and Tan shows
that intermittent pneumatic compression is superior to elastic compression stockings for deep
venous thrombosis risk reduction [35].
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The latest recommendations about this are using intermittent pneumatic compression to
prevent perioperative venous thromboembolism events in plastic surgery patients [25]. In the
absence of rigorous publications in plastic surgery, this recommendation was derived largely
from meta‐analyses in other specialties (Grade 1B). Same recommendation applies for elastic
compression stockings, but most meta‐analyses recommend the intermittent pneumatic
compression over the compression stockings (Grade 1B).
9. Effectiveness of chemoprophylaxis and bleeding risk
When we refer to chemoprophylaxis, we are referring to unfractionated heparin or low
molecular weight heparin provided at prophylactic doses. The 2012 American College of Chest
Physicians guidelines on deep venous thrombosis and pulmonary embolus prevention for
nonorthopedic surgical patients do not recommend low‐dose aspirin as first‐line venous
thromboembolism prophylaxis; as a result, experts do not recommend aspirin as first‐line
venous thromboembolism prophylaxis for plastic surgery patients.
Low‐dose aspirin is recommended as prophylaxis only when unfractionated heparin and low
molecular weight heparin are contraindicated or not available [26]. Only one study that
compared aspirin to low molecular weight heparin in 505 free flap patients showed no
difference in postoperative venous thromboembolism or bleeding. However, based on a
relative paucity of data, we could not make recommendations specific to plastic surgery
patients [36].
The oral factor Xa inhibitor “apixaban” has U.S. Food and Drug Administration approval for
stroke reduction in nonvalvular atrial fibrillation, deep venous thrombosis, and pulmonary
embolism prophylaxis after adult hip or knee replacement [37]. The oral factor Xa inhibitor
“rivaroxaban” has U.S. Food and Drug Administration approval for stroke prophylaxis in
nonvalvular atrial fibrillation, deep venous thrombosis and pulmonary embolism prophylaxis
after adult hip and knee replacement, and for treatment of deep venous thrombosis or
pulmonary embolism events [38]. Neither drug is U.S. Food and Drug Administration
approved for venous thromboembolism prophylaxis in the general surgery population.
Prior studies of patients undergoing abdominal and pelvic surgery have shown significant
venous thromboembolism risk reduction with a combination of chemoprophylaxis plus
intermittent pneumatic compression versus intermittent pneumatic compression alone [39,
40]. Meta‐analyses in high‐risk surgical patients, including a Cochrane review, showed that
combination prophylaxis significantly decreased the risk of symptomatic pulmonary embo‐
lism and symptomatic deep venous thrombosis [41, 42].
Population level data in plastic surgery did not show a significant venous thromboembolism
risk reduction with chemoprophylaxis. In addition, there was evidence of harm in the overall
population with increased rates of reoperative hematoma. These findings, paired with the
known low venous thromboembolism risk among many plastic surgery patients, suggest that
chemoprophylaxis should not routinely be provided to all plastic surgery patients [21].
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Bleeding risk with chemoprophylaxis did not show a clear trend in the risk-stratified analysis.
As 2005 Caprini score increased, estimates became less precise, as evidenced by the wider
confidence intervals. This finding has face validity, as the 2005 Caprini score has been validated
to predict risk of venous thromboembolism but not risk of bleeding. In other studies, plastic
surgery patients with 2005 Caprini scores of >8 had a 60-day venous thromboembolism rate
of 11.3% when no prophylaxis was provided, whereas chemoprophylaxis is reported to
decrease 60-day venous thromboembolism risk by 50% [43].
When plastic surgeons choose to use chemoprophylaxis, there are minimal data to support
an evidence-based recommendation for the appropriate duration of chemoprophylaxis.
However, as length of inpatient stay was variable, patients received different durations of
chemoprophylaxis. Prior work in plastic surgery has shown that among super high-risk pa-
tients (2005 Caprini score >8), venous thromboembolism events occur with the same fre-
quency at postoperative weeks 3–8 as they do at weeks 1–2. The expert panel of 2015 does
not recommend adding routine chemoprophylaxis to intermittent pneumatic compression
for venous thromboembolism prophylaxis in the general non-risk-stratified plastic surgery
population. They recommend that all plastic and reconstructive surgery patients should be
risk-stratified for perioperative venous thromboembolism risk using a 2005 Caprini score
and that surgeons consider chemoprophylaxis on a case-by-case basis in patients with Cap-
rini score >8 (Grade 1C).
10. Timing of chemoprophylaxis administration
Ultimately, the surgeon must balance the relative risks of venous thromboembolism with
chemoprophylaxis-associated venous thromboembolism risk reduction and bleeding risk in
their decision to provide chemoprophylaxis. Davison and Massoumi [44] said: “An hematoma
is a medical stress, an inconvenience, an embarrassment, or an additional procedure, but rarely
does it kill a patient. Thromboembolism that progresses to a pulmonary embolism kills the
patient 50% of the time.” The classic teaching has been that deep venous thrombosis forms in
the operating table, in response to induction of hypotension and vasodilation. Thus, initiation
of preoperative mechanical and chemoprophylaxis are conceptually appealing for venous
thromboembolism risk reduction.
The 1999 American Society of Plastic Surgeons consensus statement on deep venous throm-
bosis prophylaxis by McDevitt recommended that “thromboprophylaxis for the surgical
patient should begin before the operative procedure. All such measures are directed toward
enhancing venous flow, decreasing serum thrombogenic factors, and stabilizing the vascular
endothelium.” As such, low molecular weight heparin administered at least 2 h before surgery
was recommended for moderate-and high-risk patients, “when dissection will not be exten-
sive” [45]. However, there are insufficient data to recommend preoperative over postoperative
chemoprophylaxis for venous thromboembolism prevention in the non-risk-stratified plastic
surgery population. Also preoperative chemoprophylaxis was not associated with an in-
creased risk of hematoma compared to postoperative chemoprophylaxis in the non-risk-
stratified plastic surgery population (Grade 2C).
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11. Unfractionated heparin versus low molecular weight heparin
Many studies had very wide confidence intervals, and their aggregate effect may have skewed
data for this clinical question. There is a meta‐analysis that included 16 randomized controlled
trials and nearly 13,000 patients showed no significant difference in postoperative venous
thromboembolism, major bleeding, or minor bleeding for cancer patients who received
preoperative unfractionated heparin versus low molecular weight heparin [46].
In a single‐center study of breast surgery patients, low molecular weight heparin was sug‐
gested to have a higher risk of preoperative hematoma compared with unfractionated heparin
[47]. The data presented in the various studies are ambiguous, but there are some suggestions
based on exhaustive reviews. In conclusion, neither subtype of heparin (low molecular weight
or unfractionated) conferred an advantage over mechanical prophylaxis alone for venous
thromboembolism risk reduction in the non‐risk‐stratified plastic surgery population. Low
molecular weight but not unfractionated heparin conferred an increased risk of reoperative
hematoma in the non‐risk‐stratified plastic surgery population [25] (Grade 2C).
12. Effectiveness and bleeding risk for chemoprophylaxis by surgery type
There are special situations in plastic surgery, for example, complex reconstructions with free
flaps for breast or head and neck cancer. An analysis of transverse rectus abdominis muscu‐
locutaneous (TRAM) flap patients was unable to separate pedicled TRAM flap from free TRAM
flap breast reconstructions. Thus, these results are difficult for interpretation, as the extent of
surgery, duration of surgery, and tightness of abdominal wall closure are substantially different
between the two groups [48–50].
Patient group Intervention Recommended? Grade
All plastic surgery patients Non‐general anesthesia Yes 1C
All plastic surgery patients Intermittent pneumatic compression Yes 1B
All plastic surgery patients Chemoprophylaxis No 1C
All plastic surgery patients Preoperative risk stratification (Caprini) Yes 1C
Caprini score >8 Chemoprophylaxis Individualized 1C
All plastic surgery patients Preoperative vs. postoperative
chemoprophylaxis
Insufficient data for
recommendation
2C
All plastic surgery patients Low molecular weight vs.
unfractioned heparin
No recommendation on
medication type
2C
TRAM, body contouring,
general head and neck
Chemoprophylaxis No 2C
Head and neck free flaps Chemoprophylaxis Individualized 2C
Reproduced from Pannucci et al. [25].
Table 3. Recommendations and GRADE level.
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Head and neck reconstruction using a free flap showed a significant venous thromboembolism
risk reduction with chemoprophylaxis but also a significant increase in a composite bleeding
endpoint. Bleeding within the neck or adjacent to the airway can be life threatening and thus
has a different risk profile than prior recommendations. Surgeons must consider chemopro-
phylaxis on a case-by-case basis. After an exhaustive review of the existing literature, a
consensus recommendation was created and is summarized in Table 3.
The risk of venous thromboembolism in esthetic or reconstructive plastic surgery is real, and
complications may range from minor to life threatening. In the setting of elective surgery, all
these considerations should be strongly considered and weighed against the potential for
postoperative bleeding and secondary monitoring or interventions.
13. Conclusion
Given the morbidity and mortality associated with venous thromboembolism and the
inaccuracy of screening modalities, prevention should be the goal in this group of patients. We
recommend an individualized assessment of risk in each patient and according to the scales
presented, determine the individual risks, and the best prophylaxis to be applied before and
after the surgery.
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